Treatment

Brilique 60 mg film-coated tablets clinical trials

2 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic confirmatory (Phase III)
Evaluation of safety and efficacy of two ticagrelorbased de-escalation antiplatelet strategies in acute coronary syndrome: the randomized, multicenter, double-blind ELECTRA RCT study.
This study looks at safer ways to give blood-thinning medicines like Brilique and Aspirin after a heart attack. It compares different doses of ticagrelor to see which causes less serious bleeding while still preventing new heart problems.
For: Acute Coronary Syndrom (ACS)
Poland
Ongoing, recruitingTherapeutic confirmatory (Phase III)
Dual Antithrombotic Therapy with Dabigatran and Ticagrelor in Patients with Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (ADONIS-PCI)
This study looks at a new way to prevent blood clots and bleeding in people who have had a heart attack or similar heart problem and also have an irregular heartbeat, after having a heart procedure. It compares different doses of a blood-thinning medicine.
For: Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Poland